Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 24 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.